Steve Brozak
Stock Analyst
(n/a)
# 4,475
Out of 4,479 analysts
5
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics | Upgrades: Strong Buy | n/a | $11.93 | - | 1 | Sep 22, 2021 | |
| CWBR CohBar | Upgrades: Buy | n/a | $0.51 | - | 2 | Aug 11, 2021 | |
| OMER Omeros | Maintains: Strong Buy | n/a | $3.85 | - | 1 | Jun 18, 2021 | |
| RDHL RedHill Biopharma | Downgrades: Buy | n/a | $0.36 | - | 1 | May 28, 2021 |
Cidara Therapeutics
Sep 22, 2021
Upgrades: Strong Buy
Price Target: n/a
Current: $11.93
Upside: -
CohBar
Aug 11, 2021
Upgrades: Buy
Price Target: n/a
Current: $0.51
Upside: -
Omeros
Jun 18, 2021
Maintains: Strong Buy
Price Target: n/a
Current: $3.85
Upside: -
RedHill Biopharma
May 28, 2021
Downgrades: Buy
Price Target: n/a
Current: $0.36
Upside: -